Skip to content

Eupraxia Pharmaceuticals Inc.

EPRX Nasdaq SEC CIK 1581178

Follow Eupraxia Pharmaceuticals Weekly email: filings, results, news

News

3 stories filed under Eupraxia Pharmaceuticals

Markets

Thread · 3 stories · active today

Wedbush initiates Eupraxia Pharmaceuticals stock with Outperform rating

Markets 9 h ago

Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients

Markets 42 d ago

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Markets 43 d ago also on EP

Profile

Headquarters: VANCOUVER
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 3 stories clustered from the RSS aggregator